SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-19-013929
Filing Date
2019-08-01
Accepted
2019-08-01 07:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 75254
  Complete submission text file 0001140361-19-013929.txt   76629
Mailing Address PO BOX 1152 MEMPHIS TN 38101-1152
Business Address
HYDE JOSEPH R III (Filed by) CIK: 0000903352 (see all company filings)

State of Incorp.: TN
Type: SC 13D/A

Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Subject) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79588 | Film No.: 19990951
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences